Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 791

1.

Lactulose synergizes with CpG-ODN to modulate epithelial and immune cells cross talk.

Mukherjee R, van de Kaa M, Garssen J, Pieters RJ, Kraneveld AD, Willemsen LEM.

Food Funct. 2019 Jan 11. doi: 10.1039/c8fo02376j. [Epub ahead of print]

PMID:
30632580
2.

Strong inhibition of cholera toxin B subunit by affordable, polymer-based multivalent inhibitors.

Haksar D, de Poel E, Quarles van Ufford LHC, Bhatia S, Haag R, Beekman JM, Pieters RJ.

Bioconjug Chem. 2019 Jan 10. doi: 10.1021/acs.bioconjchem.8b00902. [Epub ahead of print]

PMID:
30629410
3.

'Why us?' Causal attributions of childhood cancer survivors, survivors' parents and community comparisons - a mixed methods analysis.

Vetsch J, Wakefield CE, Doolan EL, Signorelli C, McGill BM, Moore L, Techakesari P, Pieters R, Patenaude AF, McCarthy M, Cohn RJ; ANZCHOG Survivorship Study Group.

Acta Oncol. 2019 Jan 6:1-9. doi: 10.1080/0284186X.2018.1532600. [Epub ahead of print]

PMID:
30614350
4.

Fluorescent Trimeric Hemagglutinins Reveal Multivalent Receptor Binding Properties.

Nemanichvili N, Tomris I, Turner HL, McBride R, Grant OC, van der Woude R, Aldosari MH, Pieters RJ, Woods RJ, Paulson JC, Boons GJ, Ward AB, Verheije MH, de Vries RP.

J Mol Biol. 2018 Dec 28. pii: S0022-2836(18)30979-3. doi: 10.1016/j.jmb.2018.12.014. [Epub ahead of print]

5.

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality.

Reedijk AMJ, Klein K, Coebergh JWW, Kremer LC, Dinmohamed AG, de Haas V, Versluijs AB, Ossenkoppele GJ, Beverloo HB, Pieters R, Zwaan CM, Kaspers GJL, Karim-Kos HE.

Leukemia. 2018 Dec 19. doi: 10.1038/s41375-018-0314-7. [Epub ahead of print]

PMID:
30568171
6.

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.

de Haas V, Ismaila N, Advani A, Arber DA, Dabney RS, Patel-Donelly D, Kitlas E, Pieters R, Pui CH, Sweet K, Zhang L.

J Clin Oncol. 2019 Jan 20;37(3):239-253. doi: 10.1200/JCO.18.01468. Epub 2018 Dec 3.

PMID:
30523709
7.

Chemically modified peanut extract shows increased safety while maintaining immunogenicity.

van der Kleij HPM, Warmenhoven HJM, van Ree R, Versteeg SA, Pieters RHH, Dreskin SC, Knulst AC, Hoffen EV, Opstelten DJE, Koppelman SJ, Smit JJ.

Allergy. 2018 Dec 2. doi: 10.1111/all.13687. [Epub ahead of print]

PMID:
30506686
8.

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Biondi A, Gandemer V, De Lorenzo P, Cario G, Campbell M, Castor A, Pieters R, Baruchel A, Vora A, Leoni V, Stary J, Escherich G, Li CK, Cazzaniga G, Cavé H, Bradtke J, Conter V, Saha V, Schrappe M, Grazia Valsecchi M.

Lancet Haematol. 2018 Dec;5(12):e641-e652. doi: 10.1016/S2352-3026(18)30173-X.

PMID:
30501871
9.

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study.

Rammant E, Fonteyne V, Decaestecker K, Bultijnck R, Deforche B, Pieters R, Ost P, Verhaeghe S, Van Hecke A.

Clin Rehabil. 2018 Dec 4:269215518815531. doi: 10.1177/0269215518815531. [Epub ahead of print]

PMID:
30514109
10.

How I treat infant leukemia.

Brown P, Pieters R, Biondi A.

Blood. 2018 Nov 20. pii: blood-2018-04-785980. doi: 10.1182/blood-2018-04-785980. [Epub ahead of print]

PMID:
30459160
11.

Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1 driven B-cell precursor acute lymphoblastic leukemia.

Polak R, Bierings MB, van der Leije CS, Sanders MA, Roovers O, Marchante JRM, Boer JM, Cornelissen JJ, Pieters R, den Boer ML, Buitenhuis M.

Haematologica. 2018 Oct 31. pii: haematol.2018.193631. doi: 10.3324/haematol.2018.193631. [Epub ahead of print]

12.

Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men.

Kartaram S, Mensink M, Teunis M, Schoen E, Witte G, Janssen Duijghuijsen L, Verschuren M, Mohrmann K, M'Rabet L, Knipping K, Wittink H, van Helvoort A, Garssen J, Witkamp R, Pieters R, van Norren K.

Clin Nutr. 2018 Sep 28. pii: S0261-5614(18)32467-1. doi: 10.1016/j.clnu.2018.09.029. [Epub ahead of print]

PMID:
30340895
13.

Trovafloxacin-induced liver injury: lack in regulation of inflammation by inhibition of nucleotide release and neutrophil movement.

Giustarini G, Vrisekoop N, Kruijssen L, Wagenaar L, van Staveren S, van Roest M, Bleumink R, Bol-Schoenmakers M, Weaver R, Koenderman L, Smit J, Pieters R.

Toxicol Sci. 2018 Sep 22. doi: 10.1093/toxsci/kfy244. [Epub ahead of print]

PMID:
30247740
14.

A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.

Kloos RQH, van Litsenburg RRL, Wolf S, Wismans L, Kaspers GJL, Uyl-de Groot CA, Pieters R, van der Sluis IM.

Pediatr Blood Cancer. 2019 Jan;66(1):e27458. doi: 10.1002/pbc.27458. Epub 2018 Sep 23.

PMID:
30246496
15.

The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Berrevoets M, den Hoed MAH, Zolk O, Hoerning S, Pluijm SMF, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.

Pharmacogenet Genomics. 2018 Oct;28(10):223-229. doi: 10.1097/FPC.0000000000000352.

PMID:
30222710
16.

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.

Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M.

Haematologica. 2019 Jan;104(1):e13-e16. doi: 10.3324/haematol.2018.199422. Epub 2018 Sep 13. No abstract available.

17.

Release of Major Peanut Allergens from Their Matrix under Various pH and Simulated Saliva Conditions-Ara h2 and Ara h6 Are Readily Bio-Accessible.

Koppelman SJ, Smits M, Tomassen M, de Jong GAH, Baumert J, Taylor SL, Witkamp R, Veldman RJ, Pieters R, Wichers H.

Nutrients. 2018 Sep 11;10(9). pii: E1281. doi: 10.3390/nu10091281.

18.

A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.

Zwaan CM, Söderhäll S, Brethon B, Luciani M, Rizzari C, Stam RW, Besse E, Dutreix C, Fagioli F, Ho PA, Dufour C, Pieters R.

Br J Haematol. 2018 Sep 11. doi: 10.1111/bjh.15593. [Epub ahead of print] No abstract available.

PMID:
30203832
19.

Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids.

Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.

Medchemcomm. 2018 Apr 18;9(5):883-887. doi: 10.1039/c8md00115d. eCollection 2018 May 1.

PMID:
30108977
20.

Orthoester functionalized N-guanidino derivatives of 1,5-dideoxy-1,5-imino-d-xylitol as pH-responsive inhibitors of β-glucocerebrosidase.

Sevšek A, Sastre Toraño J, Quarles van Ufford L, Moret EE, Pieters RJ, Martin NI.

Medchemcomm. 2017 Oct 10;8(11):2050-2054. doi: 10.1039/c7md00480j. eCollection 2017 Nov 1.

21.

Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model.

Wagenaar L, Bol-Schoenmakers M, Giustarini G, Vonk MM, van Esch BCAM, Knippels LMJ, Garssen J, Smit JJ, Pieters RHH.

Mol Nutr Food Res. 2018 Oct;62(20):e1800369. doi: 10.1002/mnfr.201800369. Epub 2018 Aug 31.

PMID:
30102006
22.

Glycation of the Major Milk Allergen β-Lactoglobulin Changes Its Allergenicity by Alterations in Cellular Uptake and Degradation.

Perusko M, van Roest M, Stanic-Vucinic D, Simons PJ, Pieters RHH, Cirkovic Velickovic T, Smit JJ.

Mol Nutr Food Res. 2018 Sep;62(17):e1800341. doi: 10.1002/mnfr.201800341. Epub 2018 Jul 29.

23.

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Griffioen PH, den Hoed MAH, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.

PLoS One. 2018 Jul 9;13(7):e0199574. doi: 10.1371/journal.pone.0199574. eCollection 2018.

24.

A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Dirks NF, Heil SG, de Jonge R, Tissing WJE, Pieters R, van den Heuvel-Eibrink MM, Heijboer AC, Pluijm SMF.

Support Care Cancer. 2018 Jun 19. doi: 10.1007/s00520-018-4312-0. [Epub ahead of print]

25.

Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways.

Villeneuve DL, Landesmann B, Allavena P, Ashley N, Bal-Price A, Corsini E, Halappanavar S, Hussell T, Laskin D, Lawrence T, Nikolic-Paterson D, Pallardy M, Paini A, Pieters R, Roth R, Tschudi-Monnet F.

Toxicol Sci. 2018 Jun 1;163(2):346-352. doi: 10.1093/toxsci/kfy047.

PMID:
29850905
26.

Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL.

Bardini M, Trentin L, Rizzo F, Vieri M, Savino AM, Garrido Castro P, Fazio G, Van Roon EHJ, Kerstjens M, Smithers N, Prinjha RK, Te Kronnie G, Basso G, Stam RW, Pieters R, Biondi A, Cazzaniga G.

Mol Cancer Ther. 2018 Aug;17(8):1705-1716. doi: 10.1158/1535-7163.MCT-17-1123. Epub 2018 May 10.

PMID:
29748211
27.

Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.

van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R.

Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4.

PMID:
29727043
28.

Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.

Mena-Barragán T, García-Moreno MI, Sevšek A, Okazaki T, Nanba E, Higaki K, Martin NI, Pieters RJ, Fernández JMG, Mellet CO.

Molecules. 2018 Apr 17;23(4). pii: E927. doi: 10.3390/molecules23040927.

29.

Demystifying O-GlcNAcylation: hints from peptide substrates.

Shi J, Ruijtenbeek R, Pieters RJ.

Glycobiology. 2018 Nov 1;28(11):814-824. doi: 10.1093/glycob/cwy031.

PMID:
29635275
30.

Type 2 diabetes-related proteins derived from an in vitro model of inflamed fat tissue.

Ten Klooster JP, Sotiriou A, Boeren S, Vaessen S, Vervoort J, Pieters R.

Arch Biochem Biophys. 2018 Apr 15;644:81-92. doi: 10.1016/j.abb.2018.03.003. Epub 2018 Mar 8.

PMID:
29526533
31.

Three-dimensional analysis of the fast-start escape response of the least killifish, Heterandria formosa.

Fleuren M, van Leeuwen JL, Quicazan-Rubio EM, Pieters RPM, Pollux BJA, Voesenek CJ.

J Exp Biol. 2018 Apr 6;221(Pt 7). pii: jeb168609. doi: 10.1242/jeb.168609.

32.

Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors.

Zhang H, Laaf D, Elling L, Pieters RJ.

Bioconjug Chem. 2018 Apr 18;29(4):1266-1275. doi: 10.1021/acs.bioconjchem.8b00047. Epub 2018 Mar 7.

33.

Fish consumption from urban impoundments: What are the health risks associated with DDTs and other organochlorine pesticides in fish to township residents of a major inland city.

Pheiffer W, Wolmarans NJ, Gerber R, Yohannes YB, Ikenaka Y, Ishizuka M, Smit NJ, Wepener V, Pieters R.

Sci Total Environ. 2018 Jul 1;628-629:517-527. doi: 10.1016/j.scitotenv.2018.02.075. Epub 2018 Feb 13.

PMID:
29453181
34.

The Role of Excipients in the Stability of Triamcinolone Acetonide in Ointments.

van Heugten AJP, de Vries WS, Markesteijn MMA, Pieters RJ, Vromans H.

AAPS PharmSciTech. 2018 Apr;19(3):1448-1453. doi: 10.1208/s12249-018-0957-8. Epub 2018 Feb 15.

PMID:
29450828
35.

Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.

Kerstjens M, Pinhancos SS, Castro PG, Schneider P, Wander P, Pieters R, Stam RW.

Haematologica. 2018 Apr;103(4):e147-e150. doi: 10.3324/haematol.2017.174060. Epub 2018 Feb 1. No abstract available.

36.

Topically used corticosteroids: What is the big picture of drug product degradation?

van Heugten AJP, de Boer W, de Vries WS, Pieters RJ, Vromans H.

Eur J Pharm Sci. 2018 May 30;117:1-7. doi: 10.1016/j.ejps.2018.02.001. Epub 2018 Feb 3.

PMID:
29407556
37.

Polycyclic aromatic hydrocarbons (PAHs) in sediments from a typical urban impacted river: application of a comprehensive risk assessment.

Pheiffer W, Quinn LP, Bouwman H, Smit NJ, Pieters R.

Ecotoxicology. 2018 Apr;27(3):336-351. doi: 10.1007/s10646-018-1898-4. Epub 2018 Feb 5.

PMID:
29404865
38.

Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.

Giustarini G, Kruijssen L, van Roest M, Bleumink R, Weaver RJ, Bol-Schoenmakers M, Smit J, Pieters R.

J Appl Toxicol. 2018 May;38(5):753-765. doi: 10.1002/jat.3585. Epub 2018 Jan 26.

PMID:
29377180
39.

High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.

Steeghs EMP, Bakker M, Hoogkamer AQ, Boer JM, Hartman QJ, Stalpers F, Escherich G, de Haas V, de Groot-Kruseman HA, Pieters R, den Boer ML.

Sci Rep. 2018 Jan 12;8(1):693. doi: 10.1038/s41598-017-17704-4.

40.

Health-related fitness in very long-term survivors of childhood cancer: A cross-sectional study.

Hartman A, Pluijm SMF, Wijnen M, Neggers SJCMM, Clemens E, Pieters R, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26907. Epub 2017 Dec 22.

PMID:
29271565
41.

"In vitro" studies on galectin-3 in human natural killer cells.

Brittoli A, Fallarini S, Zhang H, Pieters RJ, Lombardi G.

Immunol Lett. 2018 Feb;194:4-12. doi: 10.1016/j.imlet.2017.12.004. Epub 2017 Dec 14.

PMID:
29248489
42.

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy.

Rammant E, Decaestecker K, Bultijnck R, Sundahl N, Ost P, Pauwels NS, Deforche B, Pieters R, Fonteyne V.

Clin Rehabil. 2018 May;32(5):594-606. doi: 10.1177/0269215517746472. Epub 2017 Dec 12.

PMID:
29231044
43.

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.

Driessen EMC, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, Vora A, Hovi L, Escherich G, Li CK, Mann G, Leblanc T, Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silverman L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R.

Leukemia. 2017 Dec;31(12):2854. doi: 10.1038/leu.2017.279.

PMID:
29210366
44.

A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.

Sutton R, Venn NC, Law T, Boer JM, Trahair TN, Ng A, Den Boer ML, Dissanayake A, Giles JE, Dalzell P, Mayoh C, Barbaric D, Revesz T, Alvaro F, Pieters R, Haber M, Norris MD, Schrappe M, Dalla Pozza L, Marshall GM.

Br J Haematol. 2018 Feb;180(4):550-562. doi: 10.1111/bjh.15056. Epub 2017 Nov 30.

PMID:
29194562
45.

High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia.

Jerchel IS, Chatzivasileiou D, Hoogkamer AQ, Boer JM, Beverloo HB, Pieters R, den Boer ML.

Haematologica. 2018 Feb;103(2):e73-e77. doi: 10.3324/haematol.2017.171702. Epub 2017 Nov 23. No abstract available.

46.

JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia.

Steeghs EMP, Jerchel IS, de Goffau-Nobel W, Hoogkamer AQ, Boer JM, Boeree A, van de Ven C, Koudijs MJ, Besselink NJM, de Groot-Kruseman HA, Zwaan CM, Horstmann MA, Pieters R, den Boer ML.

Oncotarget. 2017 Sep 16;8(52):89923-89938. doi: 10.18632/oncotarget.21027. eCollection 2017 Oct 27.

47.

Site of childhood cancer care in the Netherlands.

Reedijk AMJ, van der Heiden-van der Loo M, Visser O, Karim-Kos HE, Lieverst JA, de Ridder-Sluiter JG, Coebergh JWW, Kremer LC, Pieters R.

Eur J Cancer. 2017 Dec;87:38-46. doi: 10.1016/j.ejca.2017.09.030. Epub 2017 Nov 3.

PMID:
29107860
48.

Rationally Designed Chemically Modified Glycodendrimer Inhibits Streptococcus suis Adhesin SadP at Picomolar Concentrations.

Haataja S, Verma P, Fu O, Papageorgiou AC, Pöysti S, Pieters RJ, Nilsson UJ, Finne J.

Chemistry. 2018 Feb 6;24(8):1905-1912. doi: 10.1002/chem.201704493. Epub 2018 Jan 5.

PMID:
29094420
49.

TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.

Gooskens SL, Klasson TD, Gremmels H, Logister I, Pieters R, Perlman EJ, Giles RH, van den Heuvel-Eibrink MM.

Mol Oncol. 2018 Feb;12(2):166-179. doi: 10.1002/1878-0261.12149. Epub 2017 Dec 14.

50.

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.

Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, van der Velden V, Stary J, Zuna J, Escherich G, Stadt UZ, Aricò M, Conter V, Schrappe M, Valsecchi MG, Biondi A.

Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.

Supplemental Content

Loading ...
Support Center